Our results also suggest that anti-IL-16 therapy could be administered along with antibiotic treatment for patients with WD, as successfully reported in experimental autoimmune encephalomyelitis [42]. The gene discussed is IL16; the disease is experimental autoimmune encephalomyelitis.